These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 11119911

  • 1. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H, Tanabe K, Tokumoto T, Shimuzu T, Ishikawa N, Harano M, Inui M, Manu M, Ito S, Shimmura H, Okuda H, Yagisawa T, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract] [Full Text] [Related]

  • 2. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A.
    Transplant Proc; 1999 Nov; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
    Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Kanematsu A, Kitani R, Fuchinoue S, Oshima T, Yagisawa T, Toma H.
    Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L, Wang Y, Fu SJ, Cheng XJ.
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
    Faull RJ, Bannister KM, Russ GR, Mathew TH, Clarkson AR.
    Transplant Proc; 1999 Nov; 31(1-2):1155-6. PubMed ID: 10083516
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F, Tanabe K, Tokumoto T, Ishikawa N, Koga S, Ito S, Yagisawa T, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract] [Full Text] [Related]

  • 18. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
    Nomura Y, Tomikawa S, Beck Y, Nishimura Y, Meigata K, Ando Y, Kikuchi K.
    Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
    [No Abstract] [Full Text] [Related]

  • 19. FK506 rescue therapy for acute renal allograft rejection.
    Goh BL, Morad Z, Cheah PL, Chua CT, Tan SY.
    Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
    [No Abstract] [Full Text] [Related]

  • 20. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR, European Tacrolimus Renal Rejection Study Group.
    Transplant Proc; 2001 Nov; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.